Pharmaceutical Fluid Handling Market Statistics Report 2028

Pharmaceutical Fluid Handling Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Offering (Equipment & Solutions and Services), Tubing (Thermoplastic Elastomers, Polyvinyl Chloride, and Silicone), Application (Fluid Handling & Management, Fluid Preparation, Integration & Automation, Buffer Management, and Others), Usage (Cough Syrup, Intravenous Product, Complex Active Pharmaceutical Ingredients, and Others), and End User (Biotechnology Companies, Pharmaceutical & Medical Companies, and Others)

Publication Month : Dec 2022

  • Report Code : TIPRE00029767
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 278
Inquire Before Buy



The pharmaceutical fluid handling market is projected to reach US$ 14,209.40 million by 2028 from US$ 10,302.78 million in 2021; it is estimated to register a CAGR of 4.7% from 2022 to 2028.

Pharmaceutical fluid handling is an integral part of pharmaceutical industry to ensure that fluids such as cough syrups, intravenous products, and complex active pharmaceutical ingredients are delivered in a safe and timely manner. To succeed and be reliable, businesses need to utilize the correct handling equipment and instruments. The manufacturing divisions in the biotechnology and pharmaceutical industry require fluid control systems since their most processes involve liquid such as feed media, buffer solutions, cell extracts, and product fractions.

The pharmaceutical fluid handling market is segmented based on offering, tubing, application, usage, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the market, emphasizing on parameters such as market trends, technological advancements, and market dynamics, along with the analysis of the competitive landscape of the world's leading market players.  

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Pharmaceutical Fluid Handling Market: Strategic Insights

Market Size Value inUS$ 10,302.78 Million in 2021
Market Size Value byUS$ 14,209.40 Million by 2028
Growth rateCAGR of 4.7% from 2022 to 2028
Forecast Period2022-2028
Base Year2021
Analyst Image


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Lucrative Regions for Pharmaceutical Fluid Handling Market

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Market Insights

Rise in Adoption of Single-Use Systems (SUS) in the Pharmaceutical Industry

In pharmaceutical and biopharmaceutical product manufacturing, contamination prevention is a crucial part of the process. The proper handling and storage of fluids are essential to limit the possibility of contamination. Facility layout helps determine the method used by companies to handle fluid transfer and storage. The growing adoption of single-use systems (SUS) reduces product cross-contamination and eliminates the need for cleaning between batches, hence improving efficiency. The SUSs are made in a cleanroom; they are double bagged, and gamma, ethylene oxide, or x-ray methods are used to ensure a sterile system for every batch.

During the development of several pharmaceutical products such as vaccines, monoclonal antibodies, and personalized medicines, SUS is used as it offers a faster, simpler, and less expensive manufacturing process. Due to the rising prevalence of chronic diseases, there is a growing demand for effective drugs and products. Hence, companies are increasingly opting for SUS because it enhances the efficiency of processes and reduces costs related to cleaning, sterilization, and maintenance. In addition, low risk of contamination and low water consumption are a few factors supporting the pharmaceutical fluid handling market growth. The market growth is also attributed to increased company activities and rapid adoption of various business strategies such as collaborations, partnerships, and product launches. For instance, in April 2022, Merck signed an agreement with Wuxi National High-Tech Industrial Development Zone to expand its first Asia Pacific Mobius Single-Use manufacturing center.

Thus, the increased use of SUS in the production and transfer of sterile fluids is driving the growth of the pharmaceutical fluid handling market.

Increase in Vaccine Production

Vaccines strengthen the immune system of different age groups, providing protection against infectious diseases. In the past few decades, effective immunization has eliminated polio and smallpox, which registered high mortality rates. In recent years, there has been an increase in vaccination demand due to the rising incidences of viral and bacterial infectious diseases. Further, government foundations, hospitals, and pharmaceutical companies are focusing on regular vaccine administration by providing cost-effective immunization globally. This is boosting the demand for vaccine production, which is likely to promote the growth of the pharmaceutical fluid handling market. For instance, the Indian Universal Immunization Programme (UPI) rolled out its pneumococcal conjugate vaccine to 21 lakh children. Additionally, government funding and company investments are stimulating R&D to launch new products. According to World Health Organization, in November 2022, a total of 16 billion vaccine doses, valued at US$ 141 billion, were supplied in 2021, which is approximately three times more than the doses supplied in 2019, i.e., 5.8 billion. The Serum Institute of India (SII) postponed HPV vaccine production for two years due to the focus on the development of COVID-19 vaccines; however, it will begin supplying HPV vaccine to the Government of India by 2023 in small quantities. Thus, an increase in vaccine production is anticipated to create an opportunity for the pharmaceutical fluid handling market during the forecast period.

Tubing-Based Insights

Based on tubing, the global pharmaceutical fluid handling market is segmented into thermoplastic elastomers (TPE), polyvinyl chloride (PVC), and silicone. In 2022, the silicone segment held the largest share of the market. The TPE segment is expected to grow at the highest CAGR during 2022–2028. Thermoplastic elastomers (TPEs) offer excellent processability, making them suitable for all conventional extrusion plants and injection molding. They are cost-effective and have lower emissions and reliable reusability. High-quality, specialized tubing is vital to design a system of efficient pharmaceutical fluid processing; the pre-sterilized tubing is required to meet specific manufacturing standards, and sterilization capability is necessary when the tubing is exposed to autoclaving, gas treatment, gamma irradiation, and other sterilization methods.  A significant consideration for biopharmaceutical tubing is its welding and sealing capability; TPEs can be welded and heat-sealed. For example, on May 18, 2022, Freudenberg Medical, a manufacturer of medical and pharmaceutical devices, launched HelixFlex, which combines all benefits, i.e., weldable, translucent, sealable, and can be used in peristaltic pumping applications. A high-purity thermoplastic elastomer TPE tubing is designed for biopharmaceutical and pharmaceutical applications.

Application-Based Insights

Based on application, the pharmaceutical fluid handling market is segmented into fluid handling & management, fluid preparation, integration & automation, aseptic processing, buffer management, and others. The fluid handling & management segment held the largest market share in 2021; however, the integration & automation segment is further expected to be the largest shareholder in the market by 2028. Automation is inevitable and ever expansive. As technology continues to advance, automation shows the potential to transform processes and introduce performance improvements. In the pharmaceutical industry, the use of automation also reduces the chance of human error through its capability to consistently perform repetitive tasks. Pharmaceutical companies have been integrating automation into specific processes such as drug development, serialization, and anti-counterfeiting. In manufacturing examples, automation has become prevalent in processes such as fluid handling and management. Automation is essential for in vitro diagnostics (IVD), molecular analysis, flow cytometry, next-generation sequencing (NGS), or cell biology systems. Furthermore, combining mixing technology with filtration and fluid management permits the automated preparation of fluids using standard recipes to mix, adjust pH, and filter process buffers. Thus, growing demand for automaton is expected to drive the market for pharmaceutical fluid handling in the coming years.

Pharmaceutical fluid handling Market, by Tubing – 2021 and 2028

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Product launches and mergers and acquisitions are the highly adopted strategies by the players operating in the global pharmaceutical fluid handling market. A few of the recent key product developments are listed below:

  • In October 2022, Merck, a leading science and technology company, opened a commercial facility for its new Millipore CTDMO Services offering at the company’s site in Martillac, France.
  • In July 2022, A&G AS, based in the Estonian capital of Tallinn, has been part of the Raumedic group of companies since 2021. The company specializes in assembly in the field of medical technology and is equipped with corresponding cleanroom production space.

The COVID-19 pandemic disrupted everyday lives of people and businesses worldwide, and the pharmaceutical supply chain was greatly affected. The COVID-19 pandemic inflicted enormous pressure on healthcare infrastructure and hampered the operational capabilities of the biopharmaceutical companies and clinical laboratories. The COVID-19 pandemic led to a significant increase in industry growth, as pharmaceutical liquid handling was in high demand, as specimens had to be processed faster in the laboratory to conduct research on the COVID-19 virus. The COVID-19 vaccine development boosted the need for advanced automated liquid handling systems. As a result of the outbreak of COVID-19, the market has grown positively.

Pharmaceutical Fluid Handling – Market Segmentation

Based on offering, the market is segmented into equipment & solutions and services. The equipment & solutions is further segmented into metering pumps and capsule equipment (filling/sorting), mixing equipment and valves, thermal processing equipment (coolers/chillers/dryers/heat-exchangers), x-ray inspection systems, tanks for holding liquids and flow control products, filters/filter sets (pre-filters/ sterilizing grade filters/ virus filters), powder handling bags, sterile connectors/disconnectors and membrane filter cartridges, and others. Based on tubing, the market is segmented into TPE, PVC, and Silicone. Based on application, the market is segmented into fluid handling and management, fluid preparation, integration and automation, aseptic processing, buffer management, and others. The fluid handling and management segment is further segmented into single-use systems and multi-use systems, bioprocessing workstations, standard storage systems and biocontainers, totes, and others. Based on usage, the market is segmented into cough syrup, intravenous products, complex APIs, and others. The complex APIs segment is further categorized into vaccines, medication for cancer treatments, and others. Based on end user, the market is segmented into biotechnology companies, pharmaceutical and medical companies, and others. Based on geography, the market is divided into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), Middle East & Africa (Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa), South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Company Profiles

  • CIRCOR International Inc
  • Parker Hannifin Corp
  • Danaher Corp
  • Spirax Sarco Engineering plc
  • Merck KGaA
  • Rochling SE & Co KG
  • Tef Cap Industries Inc
  • Fraser Ross Ltd
  • Australian Fluid Handling Pty Ltd
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Offering, Tubing, Application, Usage, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Midwest, Northeast, RoAPAC, RoE, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States, West

Frequently Asked Questions

What is meant by the pharmaceutical fluid handling market?

Pharmaceutical fluid handling is an integral part of pharmaceutical industry to ensure that fluids such as cough syrups, intravenous products, and complex active pharmaceutical ingredients are delivered in a safe and timely manner. To succeed and be reliable, businesses need to utilize the correct handling equipment and instruments. The manufacturing divisions in the biotechnology and pharmaceutical industry require fluid control systems since their most processes involve liquid such as feed media, buffer solutions, cell extracts, and product fractions.

What are the driving factors for the pharmaceutical fluid handling market across the globe?

Surge in drug production and rise in adoption of single-use systems (SUS) in pharmaceutical industry are the most significant factors responsible for the overall market growth.

Which segment led the pharmaceutical fluid handling market?

Based on offering segment, the equipment segment took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.

Which usage segment held the largest market share in the pharmaceutical fluid handling market?

Based on the usage, cough syrup segment took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.

Which end user segment held the largest market share in the pharmaceutical fluid handling market?

The biotechnology companies segment dominated the pharmaceutical fluid handling market and accounted for the largest market share in 2021.

Who are the key players in the pharmaceutical fluid handling market?

CIRCOR Internatioonal Inc., Parker Hannifin Corp, Danaher Corp, Spirax Sarco Engineering plc, Merck KGaA, Rochling SE & Co KG, RAUMEDIC AG, Tef Cap Industries Inc, Fraser Ross Ltd, Australian Fluid Handling Pty Ltd among others are among the leading companies operating in the pharmaceutical fluid handling market.

The List of Companies - Pharmaceutical Fluid Handling Market

  1. CIRCOR Internatioonal Inc
  2. Parker Hannifin Corp
  3. Danaher Corp
  4. Spirax Sarco Engineering plc
  5. Merck KGaA
  6. Rochling SE & Co KG
  8. Tef Cap Industries Inc
  9. Fraser Ross Ltd
  10. Australian Fluid Handling Pty Ltd

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports